Safety Alert for - Trade Name: Ortobio Knee Arthroscopy Prosthesis ** - Registration: 80062900004 ** - Risk Class: III - HIGH RISK ** - Validity: 24/4/2017 ** - Model: Femoral Component, Patellar Component and Tibial Base Component and Tibial Plateau ** - Product Presentation: Individual sterile packaging containing = 54mm, 59mm, 64mm, 69mm, 72mm Patellar component: 26mm, 28mm, 30mm, 32mm, 34mm, 36mm, 38mm, 40mm; * = Tibial component: 54mm, 59mm, 65mm, 69mm, 72mm lateral measurement ìmedial and 8mm, 10mm, 12mm, 15mm, 18mm, 21mm, 25mm thick

According to Agência Nacional de Vigilância Sanitária (ANVISA), this safety alert involved a device in Brazil that was produced by ORTOBIO - IND E COM. DE PRODUTOS ORTOPEDICOS LTDA.

What is this?

Alerts provide important information and recommendations about products. Even though an alert has been issued, it does not necessarily mean a product is considered to be unsafe. Safety Alerts, addressed to health workers and users, may include recalls. They can be written by manufacturers, but also by health officials.

Learn more about the data here
  • Type of Event
    Safety alert
  • Event ID
    1336
  • Date
    2013-11-29
  • Event Country
  • Event Source
    ANVISA
  • Event Source URL
  • Notes / Alerts
    Brazilian data is current through June 2018. All of the data comes from Anvisa, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Brazil.
  • Extra notes in the data
    The distributors who have purchased the products are being informed regarding possible incompatibilities between the implant and instruments by means of an alert message.
  • Reason
    During investigation inspection carried out by entities of the national system of sanitary surveillance (snvs), failures were detected in the processes carried out by the company in the manufacture of the product. ## updated on 12/27/2013 - anvisa published resolution - re n ° 4,939, de december 23, 2013, determining the suspension of the dissemination, commercialization and implantation, throughout the national territory, of all products manufactured by ortobio for failing to comply with resolution 16/2013 of good manufacturing practices of medical products. (annex resolution - re no. 4,939, of december 23, 2013, published in official gazette no. 249, dated 12/24/2013, section i, page 74).
  • Action
    - Issue of alert message with the purpose of informing about the possibility of incompatibility between implant and instruments. The alert message will be sent as attachment - Alert Message. ** - Monitor the behavior of the product in the market (products already implanted) by means of contact with the clients and doctors for whom the product was commercialized. The monitoring will be carried out according to the annex - Post sale monitoring. ## UPDATED ON 05/20/201 - Publication of RESOLUTION - RE N ° 1,882, dated 05/16/2014, in DOU Nº 93 - Section 1, dated 05/19/2014, page 49, which partially revoked Resolution- RE nº 4.939, of December 23, 2013, releasing, throughout the national territory, the disclosure, commercialization and implantation of all the products listed in the table below, manufactured as of the publication date of this Resolution RE: . Orthoped Blocked Intramedullary Stem System - 80062900010; (ii). Blocking Screw for Intramedullary Rod - 80062900015; (iii). Titanium Threaded Anchor - 80062900011; (iv). Interference Bolt Romba Thread in Titanium -80062900017; (v). Sponge Bolt in Stainless Steel - 80062900018; (saw). Transverse Interference Screw - 80062900020; (vii). Special plates without rigid fixation for large and small fragments - 80062900014; (viii). Special plates blocked LPS in steel for large and small fragments - 80062900021. It should be noted that THE SUSPENSION OF THE DISCLOSURE, MARKETING AND IMPLANTS OF THE OTHER PRODUCTS MANUFACTURED BY THE COMPANY REMAINS IN FORCE. ##